Decitabine With Ruxolitinib or Fedratinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Conditions:   Acute Myeloid Leukemia;   Essential Thrombocythemia;   Myelodysplastic Syndrome;   Myelodysplastic/Myeloproliferative Neoplasm;   Myeloproliferative Neoplasm;   Myeloproliferative Neoplasm, Unclassifiable;   Polycythemia Vera;   Primary Myelofibrosis;   Secondary Myelofibrosis Interventions:   Drug: Decitabine;   Drug: Ruxolitinib;   Drug: Fedratinib Sponsors:   University of Washington;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials